Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Evexia Lifecare has informed that Meeting of the Board of Directors of the Company will be held on Friday, November 14, 2025 to consider and approve Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on September 30, 2025. Further as per the company Code of the Conduct for Prohibition of Insider Trading, the trading Window Closure period will end 48 hours after results are made public after the declaration of the said unaudited financial results for the quarter ended on September 30, 2025.
The above information is a part of company’s filings submitted to BSE.
